GlaxoSmithKline

Article image
Haleon’s debut suggests it may not be the jewel in GSK’s medicine cabinet | Nils Pratley
Consumer goods spin-off makes few waves in biggest European listing for more than a decade

Nils Pratley

18, Jul, 2022 @5:40 PM

Article image
GSK spin-off Haleon begins trading in biggest European listing in a decade
Consumer health company ends first day on London Stock Exchange with £28.5bn market valuation

Mark Sweney and Julia Kollewe

18, Jul, 2022 @8:31 AM

Article image
London stock market listing of up to £45bn looms as GSK investors vote for demerger
UK pharmaceutical firm to spin off Haleon – which will include brands such as Sensodyne and Panadol – in largest listing since 2011

Jasper Jolly

06, Jul, 2022 @5:16 PM

Article image
Hundreds of organisations breached patient data rules, reveals BMJ
Drug firms, private healthcare providers and universities among those that may be failing to protect confidentiality, says report

Andrew Gregory Health editor

11, May, 2022 @10:30 PM

Article image
Boots, Superdrug and other chemists report hay fever pill shortages
GlaxoSmithKline blames temporary manufacturing issues for lack of Piriton tablets

Julia Kollewe

10, May, 2022 @10:53 AM

Article image
GSK to buy US cancer drug developer amid pressure from activist investor
GlaxoSmithKline’s £1.5bn Sierra Oncology deal comes after pressure from Elliott to boost its pipeline

Jasper Jolly and agencies

13, Apr, 2022 @12:03 PM

Article image
GlaxoSmithKline says it will not start any new clinical trials in Russia
Pharma firm joins AstraZeneca and Pfizer in saying it will not enrol new patients into studies

Julia Kollewe

17, Mar, 2022 @12:28 PM

Article image
BP and Shell lead rush to exit Russia. There can be no going back
Oil is always a political business, and there’s no point pretending otherwise

Nils Pratley

28, Feb, 2022 @7:40 PM

Article image
GSK boss upbeat over spin-off of consumer healthcare unit
Expected to be the biggest London listing in a decade, the Haleon demerger is scheduled for July

Jasper Jolly

28, Feb, 2022 @2:53 PM

Article image
GSK unveils its new consumer brands spin-off name: Haleon
Products such as Voltaren, Sensodyne and Panadol to regroup under new stock market listing in summer

Julia Kollewe

22, Feb, 2022 @4:13 PM

Article image
Screeching U-turn as Unilever’s shareholders balk at £50bn GSK deal
Riot in ranks sends ‘strong message’ against tilt at GlaxoSmithKline’s consumer division

Nils Pratley

10, Feb, 2022 @7:47 PM

Article image
Noisy activists aside, GSK investors backed Walmsley and her strategy
The ‘step-change’ in growth for the core pharma division has barely started, but the CEO is secure for now

Nils Pratley

09, Feb, 2022 @7:04 PM

1 / 75 pages